Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
May
30
2017
Sick Stats for Medical Software Innovations Schwegman, Lundberg & Woessner, P.A.
May
10
2021
China’s National Intellectual Property Administration Starts Blocklist for Malicious Trademark Applicants Schwegman, Lundberg & Woessner, P.A.
May
28
2021
China Releases Administrative Adjudication Measures for Major Patent Infringement Disputes Effective June 1, 2021 Schwegman, Lundberg & Woessner, P.A.
Dec
12
2014
Supreme Court to Review Post-Expiration Date Royalties in Kimble v. Marvell Schwegman, Lundberg & Woessner, P.A.
Jun
13
2021
China To Reduce Stamp Tax on Intellectual Property Transactions Schwegman, Lundberg & Woessner, P.A.
Dec
16
2014
Revised 2014 Interim Guidance on Patent Subject Matter Eligibility Released by PTO Schwegman, Lundberg & Woessner, P.A.
Jun
23
2021
China National Intellectual Property Administration to Give Priority to Patent Invalidation Cases Involved in Concurrent Litigation Schwegman, Lundberg & Woessner, P.A.
Dec
30
2014
The “Top Ten” Intellectual Property Stories of 2014 (Most “Definitely”) Schwegman, Lundberg & Woessner, P.A.
Jan
21
2015
Teva v. Sandoz pt.II– The Dissent And The Zone Of Uncertainty Schwegman, Lundberg & Woessner, P.A.
Sep
24
2021
World Intellectual Property Organization Releases Global Innovation Index 2021 – China Edges Closer to Top 10 Schwegman, Lundberg & Woessner, P.A.
Feb
18
2015
“Precision Medicine” Initiative Leaves Patents “Lost in Space” Schwegman, Lundberg & Woessner, P.A.
Oct
26
2021
Zhejiang, China Fines Hangzhou Patent Firm for Not Withdrawing 164 Abnormal Patent Applications and Suspicion of Filing 1,192 Abnormal Applications in Total Schwegman, Lundberg & Woessner, P.A.
Nov
5
2021
Johnson & Johnson Medical Devices Companies Gets Patent Infringement Damages Upped 20X at China’s Supreme People’s Court Schwegman, Lundberg & Woessner, P.A.
Nov
12
2021
China to Revoke Patent Agencies’ Licenses for Filing Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Mar
24
2015
USPTO Myriad-Mayo Guidance Still Not At An Alpha Standard Schwegman, Lundberg & Woessner, P.A.
Mar
31
2011
Patent Owner Reexamination Requests with Parallel Litigation Schwegman, Lundberg & Woessner, P.A.
May
27
2011
Therasense Returns Common Sense to Law of Inequitable Conduct Schwegman, Lundberg & Woessner, P.A.
Mar
29
2022
China’s Supreme People’s Court: Patent Infringement Settlements Can Violate the Anti-Monopoly Law Schwegman, Lundberg & Woessner, P.A.
Jul
26
2011
Patent Office Proposes New Materiality Rules Schwegman, Lundberg & Woessner, P.A.
Apr
26
2022
China’s Supreme People’s Court Releases Top 10 Intellectual Property Cases of 2021 Schwegman, Lundberg & Woessner, P.A.
Apr
29
2022
China’s State Administration for Market Regulation Releases Legislative Work Plan for 2022 Schwegman, Lundberg & Woessner, P.A.
Oct
17
2011
Obviousness = Equivalence? Saint-Gobain v. Siemens Schwegman, Lundberg & Woessner, P.A.
Jul
10
2022
China’s National Intellectual Property Administration Releases Report on 2021 Patent Agency Industry – China has 60,369 Patent Agents; 47,511 Registered to Take the Patent Bar; Over Half of Patent Agencies Ordered to Make Rectifications Schwegman, Lundberg & Woessner, P.A.
Jul
14
2022
CNIPA Press Conference: Chinese Invention Patent Grants Up 16% in 2022 H1, Shanghai-Originated Invention Patent Applications Drop Due to COVID-19 Lockdown Schwegman, Lundberg & Woessner, P.A.
Jul
21
2022
CareDx v. Natera – The Broad Road to Patent Ineligibility Schwegman, Lundberg & Woessner, P.A.
Sep
6
2022
Moderna to Pfizer: “The Pandemic is Over” Schwegman, Lundberg & Woessner, P.A.
May
1
2012
Federal Circuit Orders Briefing in Myriad Remand Schwegman, Lundberg & Woessner, P.A.
Apr
12
2018
USPTO Director Outlines Challenges to the Patent System at the U.S. Chamber of Commerce Patent Policy Conference Schwegman, Lundberg & Woessner, P.A.
Dec
16
2022
EU Requests Establishment of WTO Panel in Chinese Anti-Suit Injunction Patent Cases Schwegman, Lundberg & Woessner, P.A.
Apr
24
2018
Supreme Court Decides Oil States – Inter Partes Review Does Not Violate Article III or the 7th Amendment Schwegman, Lundberg & Woessner, P.A.
Sep
26
2012
Federal Circuit Knocks Outside the Box’s Inequitable Conduct Charges Out of the Box Schwegman, Lundberg & Woessner, P.A.
Sep
2
2015
Akamai Technologies, Inc. v. Limelight Networks, Inc.: Federal Circuit brings defines liability for “joint enterprises” Schwegman, Lundberg & Woessner, P.A.
Dec
11
2018
Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability? Schwegman, Lundberg & Woessner, P.A.
Apr
13
2013
An Innovative Software Developer Speaks: Patents are Important Schwegman, Lundberg & Woessner, P.A.
May
22
2013
Patent and Trademark Office Guidance for Examiners in Wake of CLS Bank Decision: No Change for Now Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins